Generate Biomedicines to Participate in November Investor Conferences

SOMERVILLE, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Generate Biomedicines Inc. (Nasdaq: GENB) (“Generate”) today announced that members of its management team will participate in presentations at the following investor conferences: * Guggenheim 3rd Annual Healthcare Innovation Conference, Boston, Massachusetts: Monday, Nov. 9 at 1 p.m. ET * Jefferies Global Healthcare Conference, London, UK: Monday, Nov. 16 at 10:30 a.m. ET To access live webcasts of Generate’s presentations, please visit the “Events & Presentations” page within the Investors section of Generate’s website at https://investors.generatebiomedicines.com. A replay of the webcasts will be available on Generate’s website for 90 days following the event.

About Generate Biomedicines Inc. Generate (Nasdaq: GENB) is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better drug candidates for patients, faster. The Generate Platform integrates computational design with large-scale biological experimentation, enabling the creation of novel, optimized therapeutics that address historically undruggable and hard-to-drug targets, as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded in 2018, Generate is leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com or follow us on X, LinkedIn, and YouTube.